Correspondence 0001493152-23-004050 from JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC.
Date: Feb. 9, 2023 · CIK: 0001679628 · Accession: 0001493152-23-004050
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-260183
Letter
Spartan Capital Securities LLC
Broadway, 19th Floor
New York, NY 10002
February 9, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
F Street, N.E.
Washington, D.C. 20549
Re: Jupiter Neurosciences, Inc.
Registration Statement on Form S-1
CIK No. 0001679628
SEC Registration No. 333-260183
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as representative of the underwriters of the proposed offering, hereby joins the request of Jupiter Neurosciences, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:00 p.m. Eastern Time on Monday, February 13, 2023, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Thank you for your assistance with this matter.
(balance of the page intentionally left blank)
Very truly yours,
Spartan Capital Securities LLC
Show Raw Text
CORRESP
1
filename1.htm
Spartan
Capital Securities LLC
45
Broadway, 19th Floor
New
York, NY 10002
February
9, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Jupiter Neurosciences, Inc.
Registration Statement on Form S-1
CIK No. 0001679628
SEC Registration No. 333-260183
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as representative of the
underwriters of the proposed offering, hereby joins the request of Jupiter Neurosciences, Inc. that the effective date of the above-referenced
Registration Statement on Form S-1 be declared effective at 4:00 p.m. Eastern Time on Monday, February 13, 2023, or as soon as practicable
thereafter.
Pursuant
to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated
to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears
to be reasonable to secure adequate distribution of the preliminary prospectus.
The
undersigned advise that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act
of 1934, as amended.
Thank
you for your assistance with this matter.
(balance
of the page intentionally left blank)
Very truly yours,
Spartan Capital Securities LLC
By:
/s/ Jason
Diamond
Name:
Jason Diamond
Title:
Head of Investment Banking